Trial design and implementation pioneers from Cytel join peers in examining
the rise of adaptive study approaches and overcoming the remaining
challenges to wider adoption
CAMBRIDGE, Mass., June 23 /PRNewswire/ -- Cytel's renowned adaptive trial design and implementation experts Cyrus Mehta (http://www.cytel.com) and Judith Quinlan (http://www.cytel.com) will lead workshops and case study reviews at the Annual Meeting of the Drug Information Association (DIA) June 22 - 25, 2008 in Boston.
Adaptive trials are finding ever-increasing acceptance by sponsors and regulators seeking to improve clinical development productivity and reduce the rate of trial failures. Combining a wealth of experience designing and implementing adaptive trials together with over 20 years developing software for trial design, simulation and analysis, Cytel's clinical innovation know- how is unmatched.
At this year's DIA meeting, senior managers, clinicians, statisticians and trial logistics professionals from the biopharmaceutical industry will share their recent experiences with adaptive trials, and the insights gained on planning and conducting the next generation of adaptive studies.
Speaking on the latest innovative trial techniques and tools will be Cytel Co-Founder and President, Dr. Cyrus Mehta, and Vice President of Adaptive Trials, Judith Quinlan.
Dr. Mehta will join Dr. William Byrom, Vice President, Product Strategy at trial technology leader ClinPhone, for the workshop "Adaptive Design in Clinical Research", June 23, 10:30A - 12:30P.
Reporting on the PhRMA Working Group for Adaptive Trials efforts to
chronicle trial innovation successes, Cytel's Judith Quinlan presents "Are
You Ready for Adaptive Clinical Development? Examples, Case Studies,
Successes" on June 24, 8:30A - 9:30A.
See the complete DIA meeting website
and the DIA's blog site
Dr. Mehta and Vice President Quinlan are available for interviews following the DIA conference.
|SOURCE Cytel, Inc.|
Copyright©2008 PR Newswire.
All rights reserved